Drug Information

Drug General Information
Drug ID
D0KW2A
Former ID
DNC000337
Drug Name
BN50739
Drug Type
Small molecular drug
Indication Cerebral infarction [ICD10:I63] Terminated [539160], [545069]
Formula
C28H26ClN5O2S3
InChI
InChI=1S/C28H26ClN5O2S3/c1-16-31-32-24-13-30-27(18-6-4-5-7-20(18)29)26-19-10-11-33(14-23(19)39-28(26)34(16)24)25(37)15-38-17-8-9-21(35-2)22(12-17)36-3/h4-9,12H,10-11,13-15H2,1-3H3
InChIKey
MRVWRDZEYURFSW-UHFFFAOYSA-N
CAS Number
CAS 128672-07-1
PubChem Compound ID
115002
PubChem Substance ID
10236592, 12014497, 14764825, 29296583, 50070464, 50071105, 57338941, 74679892, 85209394, 85286075, 104397373, 135073326, 135650010, 136310165
Target and Pathway
Target(s) Platelet-activating factor receptor Target Info Modulator
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Staphylococcus aureus infection
NetPath Pathway IL5 Signaling Pathway
Leptin Signaling Pathway
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (q) signalling events
Interferon gamma signaling
WikiPathways GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
Small Ligand GPCRs
Interferon gamma signaling
GPCR ligand binding
GPCR downstream signaling
References
Ref 539160(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1851).
Ref 545069Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002032)